Evidence map›Paper›PMID 36837450›Full record

SynthesisMedicina (Kaunas, Lithuania)2023

Effect of Fenugreek on Hyperglycemia: A Systematic Review and Meta-Analysis.

Muhammed Shabil, Ganesh Bushi, Pavan Kalyan Bodige, Pavan Sagar Maradi, Bibhu Prasad Patra, Bijaya K Padhi, Jagdish Khubchandani

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. The Effect of Fenugreek (Health science reports · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Unlocking the Therapeutic Potential ofMedicina (Kaunas, Lithuania) · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. The Role of Fenugreek in the Management of Type 2 Diabetes.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. The effects of fenugreek (Avicenna journal of phytomedicine
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Muhammed ShabilNational Institute of Pharmaceutical Education and Research-Hajipur, Hajipur 844102, India.ORCID 0000-0003-2491-2779
Ganesh BushiNational Institute of Pharmaceutical Education and Research-Hajipur, Hajipur 844102, India.ORCID 0000-0002-0397-7904
Pavan Kalyan BodigeNational Institute of Pharmaceutical Education and Research-Hajipur, Hajipur 844102, India.ORCID 0000-0003-2859-6689
Pavan Sagar MaradiNational Institute of Pharmaceutical Education and Research-Hajipur, Hajipur 844102, India.
Bibhu Prasad PatraNational Institute of Pharmaceutical Education and Research-Hajipur, Hajipur 844102, India.
Bijaya K PadhiDepartment of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.ORCID 0000-0002-2828-2375
Jagdish KhubchandaniDepartment of Public Health, New Mexico State University, Las Cruces, NM 88003, USA.ORCID 0000-0002-9058-4278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fenugreek is used for medicinal purposes in various traditions. Some studies have demonstrated that the seeds of this plant may have an anti-diabetic effect by lowering fasting blood sugar levels and improving glucose tolerance. We conducted a systematic review of the hypoglycemic effects of fenugreek. An electronic literature search was carried out in the PubMed, Google Scholar, Scopus, and Cochrane Library databases through 18 November 2022 to find trials that assessed fasting blood glucose, postprandial blood glucose, and HbA1c changes in participants treated with fenugreek and in the control group. The mean difference with 95% confidence intervals (CI) was calculated to represent the analysis. Fourteen trials, consisting of 894 participants, were included in the meta-analysis. The results showed a reduction in fasting blood glucose levels (MD: 3.70, 95% CI of -27.02, 19.62;

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 2HyperglycemiaTrigonellaBlood GlucoseGlycated HemoglobinHumansBlood GlucoseGlycated Hemoglobinfenugreekhypoglycemiameta-analysissystematic review

Identifiers

PMID36837450
PMCPMC9962665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.